Skip to content

Clinical trials

Multiple Sclerosis, Relapsing-Remitting trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Country / region: Denmark Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20062
20072
20083
20092
20101
20112
20121
20131
20141
20151
20161
20171
20181
20201
20211
20221
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated4
Active, not recruiting3
Recruiting3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen6
Genzyme, a Sanofi Company3
Hoffmann-La Roche3
University of Aarhus3
Bayer2
Danish Research Centre for Magnetic Resonance2
Merck KGaA, Darmstadt, Germany2
Rigshospitalet, Denmark2
Amgen1
Anna Tsakiri1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting29
Multiple Sclerosis10
Multiple Sclerosis, Chronic Progressive3
Fatigue2

Trials

Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.